Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. - Wikidata - awgldk - TriplyDB

Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis.

Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis.

http://www.wikidata.org/entity/Q54463937

about

Dietary flavonoid for preventing colorectal neoplasms Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor Natural Polyphenols for Prevention and Treatment of Cancer Tomato as a Source of Carotenoids and Polyphenols Targeted to Cancer Prevention Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases Insight to drug delivery aspects for colorectal cancer Natural compounds as anticancer agents: Experimental evidence Heterologous production of curcuminoids Chemoprevention in familial adenomatous polyposis A multi-targeted approach to suppress tumor-promoting inflammation Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment Pharmacological Intervention through Dietary Nutraceuticals in Gastrointestinal Neoplasia.Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy.Immune defects in Alzheimer's disease: new medications development.Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo.Improving In Vivo Efficacy of Bioactive Molecules: An Overview of Potentially Antitumor Phytochemicals and Currently Available Lipid-Based Delivery Systems.Novel mutations and phenotypic associations identified through APC, MUTYH, NTHL1, POLD1, POLE gene analysis in Indian Familial Adenomatous Polyposis cohort Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia.Chemoprevention in patients with genetic risk of colorectal cancers Epigenetic changes induced by curcumin and other natural compounds.Curcumin and cancer: barriers to obtaining a health claim.Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases Curcumin potentiates the pro-apoptotic effects of sulindac sulfone in colorectal cancer.Colorectal cancer: chemopreventive role of curcumin and resveratrol.Diet and supplements and their impact on colorectal cancer.Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial.The multifaceted role of curcumin in cancer prevention and treatment.Curcumin's effect on intestinal inflammation and tumorigenesis in the ApcMin/+ mouse Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs.Quercetin and cancer chemoprevention Phytochemicals in cancer prevention and therapy: truth or dare?Recent advances in colorectal cancer research: the microenvironment impact.Colorectal cancer prevention through dietary and lifestyle modifications Curcumin prophylaxis mitigates the incidence of hypobaric hypoxia-induced altered ion channels expression and impaired tight junction proteins integrity in rat brain.Sulindac, 3,3'-diindolylmethane and curcumin reduce carcinogenesis in the Pirc rat, an Apc-driven model of colon carcinogenesis Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention Curcumin: updated molecular mechanisms and intervention targets in human lung cancer.

P2860

Q24201407-7EF1A61F-D3F6-462C-AFDC-562BA5F10500 Q24597964-BB527F98-A546-46B5-B6CD-220A89D444B2 Q24614491-C127B663-DFB5-4740-BD97-A117E1CF3939 Q24647242-F465A344-ED08-49E4-8B6B-5FB3D2632173 Q26739022-039CC466-5CC7-449C-B85C-9AB10B0F6CC6 Q26743401-1A8C776B-664E-48AE-8718-1EF6CAF2FB80 Q26745552-C922664E-7ECC-406E-9CB2-20503BE9A3FB Q26766052-9DD96065-6195-4711-A478-9C734FEC205A Q26774682-2F3806B1-AE42-4B0A-9A21-882CC9240264 Q26823107-47C40C11-BAB8-45A5-B7CD-B0E64CBE656E Q26824008-A7B7524A-4081-4D8F-AA27-9F13D7EC110A Q27023845-36578C37-CC06-4145-9490-BAF5C6794A20 Q28393278-7A708E6B-1078-463E-B244-547EEF8152EC Q28393316-F8BAF76A-9217-455D-BE5D-2A188DDF81B9 Q30252185-FD427935-E718-4D63-9A90-8542DE1BFFD9 Q33282319-6DFF77E7-D1A6-4376-824C-27DE6FF580D8 Q33393905-D741CCA6-2D3B-4B74-894E-F44C8418CA83 Q33500696-3170CF29-643C-46F9-8E35-81DE627A3A08 Q33710442-353812A4-DA1F-469F-85A4-EE825A7EC568 Q33714866-78FD70D7-54C5-4AE7-9FD0-C1A767206FB5 Q34060487-A55A9AE3-0C55-40D3-A29D-1F61317DFA8E Q34170508-C7988552-C833-40C7-A0F4-71BB281F8A88 Q34180255-7417D761-601D-4733-B83E-1BE2E466917A Q34478532-C015D9EA-A152-48B6-94D6-B335E930664F Q34594807-D2C10ABC-FABD-4168-BE76-6FF13D94F8F9 Q34618525-071AFF65-4648-4687-8343-A8C54DEE79C2 Q34624184-129ECFD3-35FB-4FB7-ADAA-F61B2216AFB6 Q34658072-F3AD5DA4-C7D9-4F1C-9BF9-915812B2277A Q34660475-85081EB7-6E07-4D82-B9BC-C9FBC335353A Q34667865-6EE3C972-DC68-46DC-9DC3-A87343D3B6B3 Q34722123-DDD9E926-E73A-4E28-A2EC-A27F3E1EF17C Q34976272-7684E10F-DC96-429E-AA74-45EBE8A38806 Q35106541-5C97A903-4461-48B3-ABBD-AA883ABB8350 Q35155749-9607AC7F-9C69-478E-B162-B4CB2EE8A814 Q35206650-8B138BA7-CDA5-424B-B7BE-CC15B79E054A Q35206657-ACF96E15-2B30-483C-921F-0D16B745ECEC Q35731855-EC299F6B-F306-4720-A691-9D2DBFAD6141 Q35763386-6DE496B4-23F8-475C-9E1B-E0ECA0A7BF4D Q35859243-2662DA53-7A04-4CAA-869A-E8D9A4C2B5A5 Q35866113-265227E9-1D6B-4A99-AE84-8301C37196AA

P2860

Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis.

http://www.wikidata.org/entity/Q54463937

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Combination treatment with cur ...... amilial adenomatous polyposis.

@en

Combination treatment with cur ...... amilial adenomatous polyposis.

@nl

type

label

Combination treatment with cur ...... amilial adenomatous polyposis.

@en

Combination treatment with cur ...... amilial adenomatous polyposis.

@nl

prefLabel

Combination treatment with cur ...... amilial adenomatous polyposis.

@en

Combination treatment with cur ...... amilial adenomatous polyposis.

@nl

P1433

Q54463937-75149CD5-42DF-4E18-9F0D-2E0DE5F6D809

P1476

Q54463937-E95D9DE0-97D7-46F1-8FBE-8DDC12B26153

P2093

Q54463937-48DFA14C-0FAC-466A-8FFC-53860197891B

Q54463937-57404A1D-31D6-419B-A6A5-1EBAFD8AEDDD

Q54463937-6D678483-C017-464E-8DA5-550EAB5B8A08

Q54463937-A3E953A0-DB03-4AF2-A8A7-A707F3C75716

Q54463937-B67A855B-D469-4A4B-93C5-B195CC71D8BF

Q54463937-CF29E6D6-BEC6-4050-ACF5-CCF75AA8E131

Q54463937-D1E2F13F-A16C-42E7-8531-0950AB7D9F1C

P304

Q54463937-0045449E-7B04-4FBC-80B9-9ABE308F5AE3

P31

Q54463937-82E3E813-5CCC-4435-B969-2E5BD4EBD9F0

P356

Q54463937-10D61A7B-E8E1-4728-BABC-331F8EF7D3C5

P407

Q54463937-B068D237-A3A4-44AA-8190-9B2C2F11308B

P433

Q54463937-B15D6F60-78D3-4B56-82B8-F76DD1463D8C

P478

Q54463937-DE672ABB-9E06-4851-A1BA-22BDF599646C

P577

Q54463937-EDD6E4E8-5B81-40A2-B34B-A2FD62F41373

P5875

Q54463937-9915718B-71F6-4C4D-A239-3315CDB6CFA4

P698

Q54463937-8141BE9F-9358-45BA-BFF5-9CDD79D96336

P921

Q54463937-b4b202f5-93d7-4982-9d19-2085098da309

P356

J.CGH.2006.03.020

P1433

Clinical Gastroenterology and Hepatology

P1476

Combination treatment with cur ...... amilial adenomatous polyposis.

@en

P2093

Daniel A Shoskes

http://www.w3.org/2001/XMLSchema#string

Francis M Giardiello

http://www.w3.org/2001/XMLSchema#string

Linda M Hylind

http://www.w3.org/2001/XMLSchema#string

Marcia Cruz-Correa

http://www.w3.org/2001/XMLSchema#string

Patricia Sanchez

http://www.w3.org/2001/XMLSchema#string

Rhongua Zhao

http://www.w3.org/2001/XMLSchema#string

Steven D Wexner

http://www.w3.org/2001/XMLSchema#string

P304

1035-1038

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CGH.2006.03.020

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7026235

http://www.w3.org/2001/XMLSchema#string

P698

16757216

http://www.w3.org/2001/XMLSchema#string

P921